Skip to content

Svenska Bio

Svenska Bio is Sweden's second-largest cinema chain, operating cinemas across the country.

Last updated August 25, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Svenska Bio is a Swedish cinema company headquartered in Lidingö. It operates movie theatres in cities and towns throughout Sweden and is described as the country's second-largest cinema chain. The company emerged in the late 1980s through the combination of Fornstams Biografer and a number of cinemas previously owned by Svensk Filmindustri. This formation gave the business a broader national base while retaining a connection to established Swedish cinema exhibition interests. A significant expansion took place in August 2007, when Svenska Bio acquired the Stockholm cinemas Victoria and Grand from Astoria Cinemas. The transaction strengthened the chain's presence in the capital and brought its share of the Swedish cinema market to approximately 16 percent, according to the cited reference material. The acquisition illustrates Svenska Bio's growth model: expanding its theatre network through the purchase or integration of established local and urban cinema assets rather than relying only on organic openings. The company remained a substantial national exhibitor during the 2010s. By November 2017, it operated 37 cinemas with 142 screens and 12,724 seats. By May 2018, its reach had extended to 55 Swedish cities. These figures indicate a network combining multi-screen venues with a geographically distributed presence beyond the largest metropolitan areas. Its core business is the operation of cinemas and the presentation of feature films and other screen entertainment to Swedish audiences. Ownership is divided between Peter Fornstam, who is identified as Svenska Bio's chief executive, and SF Bio. Each holds 50 percent of the company. SF Bio is described as a subsidiary of Nordic Cinema Group, which in turn belongs to Odeon Cinemas Group. Svenska Bio therefore combines private ownership associated with the Fornstam family and a major cinema-group relationship through its corporate shareholder. No separate public listing or stock-market ticker is identified in the available reference material. The available sources provide limited detail about Svenska Bio's current programme, pricing, technology, or individual theatre brands. Its documented identity is principally that of a nationwide Swedish cinema operator: a chain built from the consolidation of existing exhibitors, expanded through acquisitions, and sustained through a broad physical network of screens and seats.

History

Svenska Bio was formed in the late 1980s from a merger between Fornstams Biografer and several cinemas owned by Svensk Filmindustri. The combination created a larger Swedish cinema exhibitor from pre-existing theatre operations and established the foundation for the company's later national network. The available reference does not identify a precise incorporation date or a single founder for the merged company. The chain expanded its presence in Stockholm in August 2007 by acquiring the Victoria and Grand cinemas from Astoria Cinemas. The transaction added two established venues to Svenska Bio's portfolio and reportedly brought the company to around 16 percent of the Swedish cinema market. It was an important consolidation move within Sweden's cinema-exhibition sector and strengthened the company's position in the capital. During the following decade, Svenska Bio developed a geographically broad network. In November 2017, it was reported to operate 37 cinemas containing 142 screens and 12,724 seats. By May 2018, the company had a presence in 55 cities. These figures show an operator with substantial national reach, including locations outside Sweden's largest urban centres. The company is jointly owned. Peter Fornstam, identified as its chief executive, holds 50 percent, while SF Bio owns the remaining 50 percent. SF Bio is described in the reference material as a subsidiary of Nordic Cinema Group, which is itself a subsidiary of Odeon Cinemas Group. This ownership structure links Svenska Bio to a wider European cinema business while preserving a substantial direct ownership stake for Fornstam. Svenska Bio's documented business is cinema exhibition: operating venues, screens, and seats for public film screenings. The available sources do not provide enough information to describe specific film programmes, customer-membership products, concession brands, digital initiatives, or later corporate developments. Its recorded historical trajectory is therefore best understood through the formation of the chain, its 2007 Stockholm acquisition, and the expansion of its national theatre footprint by 2017–2018.

  • 2018

    Presence reaches 55 cities

    [1]

    By May, Svenska Bio had expanded its presence to 55 Swedish cities.

  • 2017

    Network reaches 37 cinemas

    [1]

    By November, the company operated 37 cinemas with 142 screens and 12,724 seats.

  • 2007

    Stockholm expansion through acquisition

    [1]

    Svenska Bio acquired the Victoria and Grand cinemas in Stockholm from Astoria Cinemas, reportedly reaching about 16 percent of the Swedish cinema market.

  • 1980

    Formation through merger

    [1]

    In the late 1980s, Svenska Bio was formed by combining Fornstams Biografer with several cinemas owned by Svensk Filmindustri.

Products and positioning

A major Swedish cinema exhibitor with a broad national theatre network and the scale of a leading domestic chain.

  • Cinema exhibition

    Svenska Bio cinemas

    Svenska Bio's principal offering is admission to film screenings at a distributed network of Swedish cinemas. The chain includes venues of different sizes and serves audiences in metropolitan areas as well as smaller cities. By 2017, the network was reported to include 37 cinemas, 142 screens, and 12,724 seats.

  • Cinema venues · 2007

    Victoria and Grand

    Victoria and Grand are Stockholm cinemas acquired by Svenska Bio from Astoria Cinemas in 2007. Their purchase expanded the company's presence in the Swedish capital and formed part of the chain's broader growth through the acquisition of established exhibition assets.

Brand decisions

  • 2007

    Acquisition of Victoria and GrandM&A

    Background

    Svenska Bio sought to strengthen its Stockholm presence and expand its share of the Swedish cinema market.

    Action taken

    The company bought the Victoria and Grand cinemas from Astoria Cinemas.

    Aftermath

    The transaction reportedly raised Svenska Bio's market share to approximately 16 percent.

Recent events

  • 2018

    Svenska Bio reaches 55 Swedish cities[1]

    Other

    By May 2018, the chain had expanded its geographic presence to 55 cities in Sweden.

  • 2017

    Svenska Bio operates 37 cinemas and 142 screens[1]

    Other

    By November 2017, Svenska Bio's reported network comprised 37 cinemas, 142 screens, and 12,724 seats.

  • 2007

    Svenska Bio acquires Victoria and Grand cinemas from Astoria Cinemas[1]

    M&A

    The company purchased two Stockholm cinemas, Victoria and Grand, from Astoria Cinemas. The acquisition increased Svenska Bio's position in the Swedish market to approximately 16 percent.

Sources1 sources

Cite this profile: Cite the canonical profile. /brand-wiki/svenska-bio · Editorial policy · How profiles are compiled